Reviva Pharmaceuticals (RVPH) Earnings Date, Estimates & Call Transcripts

Reviva Pharmaceuticals logo
$0.34 +0.05 (+17.96%)
As of 11/20/2026 03:57 PM Eastern

Reviva Pharmaceuticals Earnings Summary

Reviva Pharmaceuticals released Q3 2026 earnings on November 12, 2026, reporting an EPS of -$0.17, which beat the consensus estimate of -$0.29 by $0.12. With a trailing EPS of -$0.82, Reviva Pharmaceuticals' earnings are expected to grow next year, from ($2.96) to ($1.26) per share.

Latest Q3
Earnings Date
Nov. 12Estimated
Consensus EPS
(Nov. 12)
-$0.29
Actual EPS
(Nov. 12)
-$0.17 Beat By $0.12

Q3 2026 Earnings Resources

Get Reviva Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Reviva Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

RVPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Reviva Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.20-$1.00-$1.10
Q2 20263-$1.20-$0.36-$0.79
Q3 20263-$1.20-$0.40-$0.80
Q4 20263-$1.40-$0.19-$0.80
FY 202611-$5.00-$1.95-$3.48

Reviva Pharmaceuticals Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2026--$0.29-$0.17+$0.12---
8/13/2026--$0.3850-$0.19+$0.1950---
5/14/2026Q1 2026-$0.3550-$0.46 -$0.1050-$0.46--
11/13/2025Q3 2025-$2.20-$1.20+$1.00-$0.06--
8/14/2025Q2 2025-$3.00-$2.40+$0.60-$0.12--
5/15/2025Q1 2025-$4.20-$2.60+$1.60-$0.13--
3/31/2025Q4 2024-$4.40-$3.00+$1.40-$0.15--

Reviva Pharmaceuticals Earnings - Frequently Asked Questions

Reviva Pharmaceuticals (NASDAQ:RVPH) last announced its quarterly earning data on Thursday, November 12, 2026. Learn more on RVPH's earnings history.

In the previous quarter, Reviva Pharmaceuticals (NASDAQ:RVPH) reported ($0.17) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.29) by $0.12. Learn more on analysts' earnings estimate vs. RVPH's actual earnings.

Reviva Pharmaceuticals' earnings report can be found in their filing with the SEC.
View SEC filing

Reviva Pharmaceuticals (NASDAQ:RVPH) has a recorded net income of -$19.86 million. RVPH has generated -$0.82 earnings per share over the last four quarters.

Reviva Pharmaceuticals' earnings are expected to grow from ($2.96) per share to ($1.26) per share in the next year.


Earnings data for NASDAQ:RVPH is sourced from Fiscal.ai, with the most recent quarter reported on 11/12/2026. New results are added as companies report their earnings.
From Our Partners